Showing results (1381-1390 of 4,517) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Future Oncology (London, England)|June 26, 2019
Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysisAlfredo Tartarone, Giandomenico Roviello, Rosa Lerose, et al.
Future Oncology (London, England)|June 26, 2019
Clinical implications of mismatch repair deficiency in prostate cancerRamy Sedhom, Emmanuel S Antonarakis
Future Oncology (London, England)|July 2, 2019
High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancerXin Zhou, Yan-Na Shang, Ran Lu, et al.
Future Oncology (London, England)|January 31, 2022
Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapyNehemiah Kebede, Ruchit Shah, Anuj Shah, et al.
Future Oncology (London, England)|February 2, 2022
Nomogram predicting prostate cancer in patients with negative prebiopsy multiparametric magnetic resonanceMing Chen, Ren Wang, Tingting Zhang, et al.
Future Oncology (London, England)|February 2, 2022
Association of polymorphisms in PIN1 with progression and susceptibility in gastric cancerLi Huang, Ruixian Luo, Ziji Yang, et al.
Future Oncology (London, England)|February 2, 2022
Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor responseCe Wang, Guoshuang Feng, Jingjing Zhu, et al.
Future Oncology (London, England)|February 4, 2022
Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based studyQin-Yu Yang, Chao-Tao Tang, Yun-Feng Huang, et al.
Future Oncology (London, England)|February 4, 2022
Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosisHollie Pilkington, Sarah Smith, Neil Roskell, et al.
Pageof 452